About
TC Biopharm develops an off-the-shelf allogeneic gamma delta T cell therapy platform intended to be scalable. The company focuses on cell-based immunotherapies using gamma delta T cells.
Explore TC Biopharm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.